Dehinel Plus, 150 mg + 144 mg + 50 mg, tabletki dla psów
Dehinel Plus, 150 mg + 144 mg + 50 mg, tabletki dla psów
Not authorised
- Praziquantel
- Pyrantel embonate
- Febantel
Product identification
Medicine name:
Dehinel Plus, 150 mg + 144 mg + 50 mg, tabletki dla psów
Active substance:
- Praziquantel
- Pyrantel embonate
- Febantel
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Praziquantel50.00/milligram(s)1.00Tablet
-
Pyrantel embonate144.00/milligram(s)1.00Tablet
-
Febantel150.00/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP52AC55
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Poland
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Well-established use application (Article 13a of Directive No 2001/82/EC)
Marketing authorisation holder:
- KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
- Krka-Farma d.o.o.
- KRKA tovarna zdravil d.d. Novo mesto
Responsible authority:
- Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
- 1642
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022
Labelling
This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022